Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)

por Nilsson, B, Sjölund, K, Kindblom, L-G, Meis-Kindblom, J M, Bümming, P, Nilsson, O, Andersson, J, Ahlman, H
Publicado 2007

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients

por Bümming, P, Andersson, J, Meis-Kindblom, J M, Klingenstierna, H, Engström, K, Stierner, U, Wängberg, B, Jansson, S, Ahlman, H, Kindblom, L-G, Nilsson, B
Publicado 2003

Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma

por Haniball, J., Sumathi, V. P., Kindblom, L.-G., Abudu, A., Carter, S. R., Tillman, R. M., Jeys, L., Spooner, D., Peake, D., Grimer, R. J.
Publicado 2011